Tested Applications
| Positive WB detected in | A549 cells, COLO 320 cells, HeLa cells, Jurkat cells, LNCaP cells |
| Positive IP detected in | COLO 320 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20439-1-AP targets CLK1 in WB, IP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag14214 Product name: Recombinant human CLK1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-143 aa of BC031549 Sequence: MRHSKRTYCPDWDDKDWDYGKWRSSSSHKRRKRSHSSAQENKRCKYNHSKMCDSHYLESRSINEKDYHSRRYIDEYRNDYTQGCEPGHRQRDHESRYQNHSSKSSGRSGRSSYKSKHRIHHSTSHRRSHGKSHRRKRTRSVED Predict reactive species |
| Full Name | CDC-like kinase 1 |
| Calculated Molecular Weight | 484 aa, 57 kDa |
| Observed Molecular Weight | 62 kDa |
| GenBank Accession Number | BC031549 |
| Gene Symbol | CLK1 |
| Gene ID (NCBI) | 1195 |
| RRID | AB_2878686 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P49759 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
CLK1 (CDC-like kinase 1) is the dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. It phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. It can phosphorylate: SRSF1, SRSF3 and PTPN1 (PMID: 10480872; 19168442). It also regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells (PMID: 19168442). Elevated CLK1 activity is frequently detected in cancers, where it alters splice isoform balance to promote proliferation, invasion and chemoresistance, making it an emerging therapeutic target.
Protocols
| Product Specific Protocols | |
|---|---|
| IP protocol for CLK1 antibody 20439-1-AP | Download protocol |
| WB protocol for CLK1 antibody 20439-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CLK1 Polyclonal antibody (catalog number 20439-1-AP) has 2 total citations. Both appear in Frontiers journals: Frontiers in Immunology (2024) and Frontiers in Cell and Developmental Biology (2026). The research fields involve cancer biology, specifically osteosarcoma and non-small cell lung cancer (NSCLC), focusing on CLK1's role as an immune cell marker and tumor suppressor in disease progression, cell proliferation, and immune infiltration. Both studies used the antibody for Western blot (WB) in human samples.
| Species | Application | Title |
|---|---|---|
Front Immunol Machine learning-based selection of immune cell markers in osteosarcoma: prognostic determination and validation of CLK1 in disease progression | ||
Front Cell Dev Biol CLK1 is a potential tumor suppressor for NSCLC by regulating cell proliferation and immune infiltration. |









